REPLIMUNE GROUP, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
REPLIMUNE GROUP, INC. (REPL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.17 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.17M shares, a 2.99% increase year-over-year.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 17.52K shares, a 91.57% decline year-over-year.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 33.41K shares, a 38.43% decline year-over-year.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 46.05K shares, a 75.17% decline year-over-year.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 2.20M shares, a 0.43% increase from fiscal 2025.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.19M shares, a 8.45% decline from fiscal 2024.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.39M shares, a 49.21% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.60M shares, a 1.95% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.17M shares 10-Q · filed 2026-08-14 | 2.18M shares derived: sum of 2 quarters · filed 2026-08-14 | 2.22M shares derived: sum of 3 quarters · filed 2026-08-14 | 2.26M shares derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 17.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | 50.93K shares derived: sum of 2 quarters · filed 2026-06-29 | 96.98K shares derived: sum of 3 quarters · filed 2026-06-29 | 2.20M shares 10-K · filed 2026-06-29 | ||||
| 2025-12-31 | 33.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | 79.47K shares derived: sum of 2 quarters · filed 2026-02-03 | 2.18M shares 10-Q · filed 2026-02-03 | 2.39M shares derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2025-09-30 | 46.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 2.15M shares 10-Q · filed 2025-11-06 | 2.36M shares derived: sum of 3 quarters · filed 2025-11-06 | 2.41M shares derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2025-06-30 | 2.10M shares 10-Q · filed 2025-08-07 | 2.31M shares derived: sum of 2 quarters · filed 2025-08-07 | 2.37M shares derived: sum of 3 quarters · filed 2025-08-07 | 2.55M shares derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2025-03-31 | 207.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | 262.04K shares derived: sum of 2 quarters · filed 2025-05-22 | 447.51K shares derived: sum of 3 quarters · filed 2025-05-22 | 2.19M shares 10-K · filed 2025-05-22 | ||||
| 2024-12-31 | 54.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-12 | 239.74K shares derived: sum of 2 quarters · filed 2025-02-12 | 1.98M shares 10-Q · filed 2025-02-12 | 2.25M shares derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2024-09-30 | 185.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | 1.93M shares 10-Q · filed 2024-11-12 | 2.19M shares derived: sum of 3 quarters · filed 2024-11-12 | 2.26M shares derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2024-06-30 | 1.74M shares 10-Q · filed 2024-08-08 | 2.01M shares derived: sum of 2 quarters · filed 2024-08-08 | 2.07M shares derived: sum of 3 quarters · filed 2024-08-08 | 2.34M shares derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2024-03-31 | 261.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | 329.60K shares derived: sum of 2 quarters · filed 2024-05-16 | 591.72K shares derived: sum of 3 quarters · filed 2024-05-16 | 2.39M shares 10-K · filed 2024-05-16 | ||||
| 2023-12-31 | 67.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | 329.75K shares derived: sum of 2 quarters · filed 2024-02-08 | 2.13M shares 10-Q · filed 2024-02-08 | 2.22M shares derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2023-09-30 | 125.00K shares 10-Q · filed 2024-02-08 | 262.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | 2.06M shares 10-Q · filed 2023-11-07 | 2.15M shares derived: sum of 3 quarters · filed 2023-11-07 | 2.34M shares derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2023-06-30 | 1.80M shares 10-Q · filed 2023-08-03 | 1.89M shares derived: sum of 2 quarters · filed 2023-08-03 | 2.08M shares derived: sum of 3 quarters · filed 2023-08-03 | 2.14M shares derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2023-03-31 | 89.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | 278.60K shares derived: sum of 2 quarters · filed 2023-05-18 | 338.98K shares derived: sum of 3 quarters · filed 2023-05-18 | 1.60M shares 10-K · filed 2023-05-18 | ||||
| 2022-12-31 | 82.50K shares 10-Q · filed 2024-02-08 | 82.50M shares 10-Q · filed 2023-02-09 | 188.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 249.01K shares derived: sum of 2 quarters · filed 2023-02-09 | 1.51M shares 10-Q · filed 2023-02-09 | 1.61M shares derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2022-09-30 | 60.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | 1.33M shares 10-Q · filed 2022-11-03 | 1.42M shares derived: sum of 3 quarters · filed 2022-11-03 | 1.59M shares derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2022-06-30 | 1.27M shares 10-Q · filed 2022-08-04 | 1.36M shares derived: sum of 2 quarters · filed 2022-08-04 | 1.53M shares derived: sum of 3 quarters · filed 2022-08-04 | 1.61M shares derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2022-03-31 | 97.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | 264.77K shares derived: sum of 2 quarters · filed 2022-05-19 | 349.05K shares derived: sum of 3 quarters · filed 2022-05-19 | 1.57M shares 10-K · filed 2022-05-19 | ||||
| 2021-12-31 | 167.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | 251.69K shares derived: sum of 2 quarters · filed 2022-02-03 | 1.48M shares 10-Q · filed 2022-02-03 | 1.82M shares derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2021-09-30 | 84.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | 1.31M shares 10-Q · filed 2021-11-04 | 1.65M shares derived: sum of 3 quarters · filed 2021-11-04 | 1.85M shares derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2021-06-30 | 1.22M shares 10-Q · filed 2021-08-06 | 1.56M shares derived: sum of 2 quarters · filed 2021-08-06 | 1.77M shares derived: sum of 3 quarters · filed 2021-08-06 | 2.13M shares derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2021-05-31 | 125.00K shares 10-Q · filed 2024-02-08 | 125.00M shares 10-Q · filed 2021-08-06 | 125.00K shares 10-K · filed 2023-05-18 | |||||
| 2021-03-31 | 338.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | 541.01K shares derived: sum of 2 quarters · filed 2021-05-20 | 901.01K shares derived: sum of 3 quarters · filed 2021-05-20 | 2.62M shares 10-K · filed 2021-05-20 | ||||
| 2020-12-31 | 202.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04 | 562.50K shares derived: sum of 2 quarters · filed 2021-02-04 | 2.28M shares 10-Q · filed 2021-02-04 | 2.41M shares derived: sum of 4 quarters · filed 2021-02-04 | ||||
| 2020-09-30 | 360.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | 2.08M shares 10-Q · filed 2020-11-05 | 2.20M shares derived: sum of 3 quarters · filed 2020-11-05 | 2.52M shares derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2020-06-30 | 1.72M shares 10-Q · filed 2020-08-07 | 1.84M shares derived: sum of 2 quarters · filed 2020-08-07 | 2.16M shares derived: sum of 3 quarters · filed 2020-08-07 | 2.23M shares derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2020-03-31 | 121.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | 437.00K shares derived: sum of 2 quarters · filed 2020-06-03 | 507.00K shares derived: sum of 3 quarters · filed 2020-06-03 | 1.64M shares 10-K · filed 2020-06-03 | ||||
| 2019-12-31 | 315.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | 385.50K shares derived: sum of 2 quarters · filed 2020-02-13 | 1.52M shares 10-Q · filed 2020-02-13 | 1.61M shares derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2019-09-30 | 70.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | 1.20M shares 10-Q · filed 2019-11-12 | 1.29M shares derived: sum of 3 quarters · filed 2019-11-12 | 1.40M shares derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2019-06-30 | 1.13M shares 10-Q · filed 2019-08-14 | 1.22M shares derived: sum of 2 quarters · filed 2019-08-14 | 1.33M shares derived: sum of 3 quarters · filed 2019-08-14 | |||||
| 2019-03-31 | 91.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-28 | 199.00K shares derived: sum of 2 quarters · filed 2019-06-28 | 1.37M shares 10-K · filed 2019-06-28 | |||||
| 2018-12-31 | 108.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | 1.28M shares 10-Q · filed 2019-02-14 | ||||||
| 2018-09-30 | 1.17M shares 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |